TRHC - Tabula Rasa HealthCare, Inc.
64.93 0.00 (0.00%)
After hours: 4:00PM EDT
| Previous Close | 63.50 |
| Open | 64.25 |
| Bid | 64.93 x 800 |
| Ask | 75.00 x 800 |
| Day's Range | 63.84 - 65.57 |
| 52 Week Range | 40.86 - 91.16 |
| Volume | 195,842 |
| Avg. Volume | 343,982 |
| Market Cap | 1.434B |
| Beta (3Y Monthly) | 1.61 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.89 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 82.64 |
- GuruFocus.com
Tabula Rasa Healthcare Inc (TRHC) CEO Calvin H Knowlton Sold $513,040 of Shares
CEO of Tabula Rasa Healthcare Inc (30-Year Financial, Insider Trades) Calvin H Knowlton (insider trades) sold 8,000 shares of TRHC on 08/19/2019 at an average price of $64.13 a share. Continue reading...
- GlobeNewswire
TRHC to Provide Comprehensive Medication Review Opportunities to Community Pharmacists
Tabula Rasa HealthCare (TRHC) a leading provider of technology-enabled solutions to mitigate medication risk and reduce medical costs, today announced a new offering of Comprehensive Medication Review (CMR) opportunities to community pharmacists through the collaboration of two of its subsidiary companies, SinfoníaRx (SRx) and PrescribeWellness (PW). Community pharmacists now will have the opportunity to conduct face-to-face CMRs with their patients and receive compensation for additional clinical services. “Engaging community pharmacists to provide in-person CMRs through PW’s Patient Engagement Center enhances our current solution and will further our efforts to expand community pharmacy practice,” explained TRHC Chairman and CEO Calvin H. Knowlton, PhD.
Motley FoolTabula Rasa HealthCare, Inc. Common Stock (TRHC) Q2 2019 Earnings Call Transcript
TRHC earnings call for the period ending June 30, 2019.
- Zacks
Tabula Rasa Healthcare (TRHC) Surpasses Q2 Earnings and Revenue Estimates
Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 600.00% and 8.69%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Tabula Rasa HealthCare Announces Second Quarter 2019 Operating Results
MOORESTOWN, N.J., Aug. 08, 2019 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today.
- Simply Wall St.
How Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Can Impact Your Portfolio Volatility
Anyone researching Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) might want to consider the historical volatility of the...
- GuruFocus.com
Tabula Rasa Healthcare Inc (TRHC) CFO Brian W Adams Sold $600,000 of Shares
CFO of Tabula Rasa Healthcare Inc (30-Year Financial, Insider Trades) Brian W Adams (insider trades) sold 10,000 shares of TRHC on 07/31/2019 at an average price of $60 a share. Continue reading...
- Zacks
Analysts Estimate Tabula Rasa Healthcare (TRHC) to Report a Decline in Earnings: What to Look Out for
Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire
Tabula Rasa HealthCare Executive to Present at EXPO.health 2019
Tabula Rasa HealthCare (TRHC), a healthcare technology company advancing the field of medication safety, today announced Senior Vice President for Healthcare Analytics Alan Stein, MD, PhD, will present on the topic of data science at the EXPO.health 2019 conference to be held July 31-August 2 in Boston, Mass.
- GlobeNewswire
Tabula Rasa Healthcare to Announce Second Quarter 2019 Operating Results and Host Conference Call on Thursday, August 8, 2019
MOORESTOWN, N.J., July 23, 2019 -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, will release its second.
- Zacks
NXGN or TRHC: Which Is the Better Value Stock Right Now?
NXGN vs. TRHC: Which Stock Is the Better Value Option?
- GlobeNewswire
TRHC and CQuentia Announce Collaboration to Leverage Scientific and Technology Resources to Provide Pharmacogenomic Services and Biometric Wearable Products to Patients and Providers
Tabula Rasa HealthCare, Inc. (“TRHC”) (TRHC), a leading provider of technology-enabled solutions to mitigate medication risk, reduce medical costs, and optimize client performance, today announced it has signed two agreements to collaborate with CQuentia. CQuentia is a comprehensive analytics platform for personalized medicine, integrating genetic test results with scientific and clinical action. The collaboration will bring a robust suite of cutting-edge pharmacogenomics services and biometric wearable products to patients and providers. “CQuentia has selected TRHC’s MedWise™ as its preferred method for delivering pharmacogenomics (PGx) lab results back to ordering physicians,” said CQuentia CEO Alan Meeker.
- Simply Wall St.
Is Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) A Financially Sound Company?
Investors are always looking for growth in small-cap stocks like Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), with a...
- GlobeNewswire
Houston Methodist Selects Tabula Rasa HealthCare’s DoseMe For System-wide Precision Dosing Technology
MOORESTOWN, N.J., June 13, 2019 -- Tabula Rasa HealthCare, Inc.’s (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today.
- GlobeNewswire
Tabula Rasa HealthCare’s Dr. Sandra Leal is President-elect American Pharmacists Association
Tabula Rasa HealthCare, Inc. (“TRHC”) (TRHC), a healthcare technology company advancing the field of medication safety, commends the recent election of Sandra Leal, PharmD, MPH, FAPhA, CDE as the 2020-2021 American Pharmacists Association (APhA) President-elect. Dr. Leal, Chief Executive Officer (CEO) of TRHC subsidiary SinfoníaRx, will assume the office of APhA President in 2021, leading the United States’ first-established and largest association of pharmacists.
- Simply Wall St.
Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Insiders Increased Their Holdings
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
- GlobeNewswire
Tabula Rasa HealthCare’s DoseMe Signs 3-Year Agreement with Portugal’s National Health Service
Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), precision dosing software company DoseMe, today announced a three-year agreement with Portugal’s National Health Service, Centro Hospitalar Lisboa Ocidental (CHLO) for DoseMe’s proprietary dose optimization software - DoseMeRx. “Therapeutic drug monitoring of medications that have a narrow therapeutic window is a challenging element for any hospital pharmacy team, and our center has a long tradition of it.
- Zacks
NXGN vs. TRHC: Which Stock Is the Better Value Option?
NXGN vs. TRHC: Which Stock Is the Better Value Option?
- GlobeNewswire
Tabula Rasa HealthCare to Participate in Upcoming Investor Conferences
MOORESTOWN, N.J., May 22, 2019 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced.
- GlobeNewswire
TRHC’s Capstone Performance Systems Gains New Clients and Expands Services in 1Q19
Capstone Performance Systems, a subsidiary of Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a leading provider of technology-enabled solutions to mitigate medication risk and improve health plan operations, has introduced new services and gained additional PACE (Program of All-inclusive Care for the Elderly) clients in the first quarter of 2019. Its expanding client roster includes two new PACE clients in Michigan, which recently began receiving Capstone risk adjustment and concurrent coding services.
Motley FoolTabula Rasa HealthCare, Inc. Common Stock (TRHC) Q1 2019 Earnings Call Transcript
TRHC earnings call for the period ending March 31, 2019.
- Zacks
Tabula Rasa Healthcare (TRHC) Q1 Earnings and Revenues Surpass Estimates
Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 66.67% and 2.90%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
